Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Watch Teva CEO on Second-Quarter, Potential DOJ Settlement - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Where is Kåre Schultz? | Ctech
Teva names Richard Francis to replace CEO Schultz - Medical Buyer
Teva decided to appoint Richard Francis as President and CEO replacing Kar Schultz after 5 years :: Israeli Financial News - The Israeli Economic World
Teva paid top executives $330m while share price tanked - Globes
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Kåre Schultz lands first chairmanship following Teva exit — MedWatch
Teva to depend on innovation as it seeks end to revenue slide
Teva CEO says production and distribution in Israel remain largely unaffected by war | The Times of Israel
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Kåre Schultz Teva Pharmaceuticals CEO Rating | Comparably
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Richard Francis - Teva Pharmaceuticals | LinkedIn
Teva CEO Erez Vigodman Steps Down | CHEManager
